Viewing Study NCT03016468


Ignite Creation Date: 2025-12-24 @ 5:54 PM
Ignite Modification Date: 2026-04-23 @ 3:30 PM
Study NCT ID: NCT03016468
Status: WITHDRAWN
Last Update Posted: 2017-04-11
First Post: 2017-01-06
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety of Transition From Selexipag to Remodulin® Then Oral Treprostinil in Symptomatic Adult PAH
Sponsor: United Therapeutics
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module